Moderna Investor
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
Technology:
COVID
Industry:
Vaccine/Drug
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
2010-01-01
Employees Number:
1001-5000
Funding Status:
N/A
Investor Type:
N/A
Investment Stage:
N/A
Number Of Exits:
N/A
Acquisitions Number:
Made Acquisitions
Total Funding:
2981600000
Estimated Revenue:
$100M to $500M
Last Funding Date:
2022-10-12
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership